Clinical Trial Update: To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is planned to evaluate the efficacy and safety of JPI-547 in combination with bevacizumab as maintenance therapy for relapsed ovarian c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• JPI-547

Snippet

Sponsor: Onconic Therapeutics Inc. | Conditions: Ovarian Cancer | Phase 2 | Status: NOT_YET_RECRUITING